A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
Clinical trial NCT04025879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04025879
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2023-07-26
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.